Management of postmyocardial infarction in the elderly patient

Robert Forman, W. S. Aronow

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Elderly patients have a significantly higher mortality and morbidity compared with younger patients in the postmyocardial infarction period and thus, with the appropriate management have a greater potential for benefit compared with younger patients. It has been shown in the large randomized trials that elderly patients with acute myocardial infarction benefit significantly from administration of beta-blocking agents and angiotensin- converting enzyme inhibitors. Aspirin and warfarin sodium (Coumadin) have been shown to benefit patients of all age groups. Secondary prevention with cessation of smoking, use of lipid -lowering agents, treatment of hypertension, and estrogen therapy in the postmenopausal woman have been shown to be effective. Elderly patients, therefore, who are free of general noncardiac disability and who can be expected to live meaningful lives should be offered a comprehensive program to reduce their cardiac morbidity and mortality after discharge following acute myocardial infarction.

Original languageEnglish (US)
Pages (from-to)169-180
Number of pages12
JournalClinics in Geriatric Medicine
Volume12
Issue number1
StatePublished - 1996

Fingerprint

Infarction
Warfarin
Myocardial Infarction
Morbidity
Mortality
Smoking Cessation
Secondary Prevention
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Estrogens
Age Groups
Hypertension
Lipids
Therapeutics

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Management of postmyocardial infarction in the elderly patient. / Forman, Robert; Aronow, W. S.

In: Clinics in Geriatric Medicine, Vol. 12, No. 1, 1996, p. 169-180.

Research output: Contribution to journalArticle

@article{788b47b39aaf47339925f70d7816c054,
title = "Management of postmyocardial infarction in the elderly patient",
abstract = "Elderly patients have a significantly higher mortality and morbidity compared with younger patients in the postmyocardial infarction period and thus, with the appropriate management have a greater potential for benefit compared with younger patients. It has been shown in the large randomized trials that elderly patients with acute myocardial infarction benefit significantly from administration of beta-blocking agents and angiotensin- converting enzyme inhibitors. Aspirin and warfarin sodium (Coumadin) have been shown to benefit patients of all age groups. Secondary prevention with cessation of smoking, use of lipid -lowering agents, treatment of hypertension, and estrogen therapy in the postmenopausal woman have been shown to be effective. Elderly patients, therefore, who are free of general noncardiac disability and who can be expected to live meaningful lives should be offered a comprehensive program to reduce their cardiac morbidity and mortality after discharge following acute myocardial infarction.",
author = "Robert Forman and Aronow, {W. S.}",
year = "1996",
language = "English (US)",
volume = "12",
pages = "169--180",
journal = "Clinics in Geriatric Medicine",
issn = "0749-0690",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Management of postmyocardial infarction in the elderly patient

AU - Forman, Robert

AU - Aronow, W. S.

PY - 1996

Y1 - 1996

N2 - Elderly patients have a significantly higher mortality and morbidity compared with younger patients in the postmyocardial infarction period and thus, with the appropriate management have a greater potential for benefit compared with younger patients. It has been shown in the large randomized trials that elderly patients with acute myocardial infarction benefit significantly from administration of beta-blocking agents and angiotensin- converting enzyme inhibitors. Aspirin and warfarin sodium (Coumadin) have been shown to benefit patients of all age groups. Secondary prevention with cessation of smoking, use of lipid -lowering agents, treatment of hypertension, and estrogen therapy in the postmenopausal woman have been shown to be effective. Elderly patients, therefore, who are free of general noncardiac disability and who can be expected to live meaningful lives should be offered a comprehensive program to reduce their cardiac morbidity and mortality after discharge following acute myocardial infarction.

AB - Elderly patients have a significantly higher mortality and morbidity compared with younger patients in the postmyocardial infarction period and thus, with the appropriate management have a greater potential for benefit compared with younger patients. It has been shown in the large randomized trials that elderly patients with acute myocardial infarction benefit significantly from administration of beta-blocking agents and angiotensin- converting enzyme inhibitors. Aspirin and warfarin sodium (Coumadin) have been shown to benefit patients of all age groups. Secondary prevention with cessation of smoking, use of lipid -lowering agents, treatment of hypertension, and estrogen therapy in the postmenopausal woman have been shown to be effective. Elderly patients, therefore, who are free of general noncardiac disability and who can be expected to live meaningful lives should be offered a comprehensive program to reduce their cardiac morbidity and mortality after discharge following acute myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0030031673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030031673&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 169

EP - 180

JO - Clinics in Geriatric Medicine

JF - Clinics in Geriatric Medicine

SN - 0749-0690

IS - 1

ER -